Request a Demo

Stay Ahead of Cancer

CancerIQ makes it possible for providers to connect all patients to the latest innovations in cancer prevention, early detection, and treatment. Join our team – we're hiring!

The Problem

Cancer is being diagnosed at earlier ages and later stages

"Sarah" provides her family history at intake, generating a follow-up letter stating her lifetime breast cancer risk: >20% — a number that appears low. The Tyrer-Cuzick model recommends ordering a breast MRI.

Without genetic testing, the BRCA mutation that Sarah carried was never discovered, meaning she faced a significantly higher hereditary risk of a breast cancer diagnosis than the average woman.

The patient is diagnosed with late-stage breast cancer, leaving her asking a simple but difficult question: “Why didn’t anyone catch this sooner?”

Group 1
Colon Cancer Awareness Month Social (2)

Hear CancerIQ Co-Founder and CEO Feyi Olopade Ayodele unpack how a one-size-fits-all approach to cancer care fails to meet the needs of the 1 in 10 patients with the highest risk of a cancer diagnosis.

The Challenge

Most healthcare providers take a one-size-fits-all approach to breast care. This is bad for patient care — and it is bad for business.

More than 257,000 new cases of breast cancer are diagnosed in the United States annually; as many as 10% due to genetic or familial risk factors that can be addressed in advance.

Group 1
Our Vision

Let’s end cancer as we know it by detecting it earlier or preventing it altogether

To get ahead of cancer and save more lives, we must expand access to the latest clinical and genomic innovations across all patient populations.

Who We Are

We're a team of passionate individuals from diverse backgrounds that is dedicated to helping patients access the information they need to lower their cancer risk.

Meet the Leadership Team

Feyi Olopade Ayodele 2021 Headshot (Small)

Feyi Olopade Ayodele, MBA

Co-Founder, Chief Executive Officer


Haibo Lu, MBA

Co-Founder, VP of Product and Customer Success


Olufunmilayo (Funmi) Olopade, MD

Co-Founder, Chief Scientific Advisor


Christopher Bun, PhD

Chief Scientific Officer


Laku Adedoyin

Chief Technology Officer


Paul Burton, JD, MBA

Chief Financial Officer


Sharon Ray

Head of People and Operations


John Hansel

SVP, Commercial Strategy


Matt Valin

VP, Sales